JPRN-UMIN000027631招募中未知
Randomized phase II study of TJ-3020 in patients with unresectable advanced or recurrent pancreatic cancer receiving nab-Paclitaxel plus Gemcitabine - Randomized phase II study of TJ-3020 in patients with unresectable advanced or recurrent pancreatic cancer receiving nab-Paclitaxel plus Gemcitabine
agoya University0 个研究点目标入组 56 人开始时间: 2017年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who have allergies to traditional Chinese medicine 2) Patients with mental disorder or severe co-morbidity such as heart failure, renal failure, or bowel obstruction 3) Patients with pregnancy 4) Patients with intorerable of oral medications 5) Patients with active cancer of other organs 6) Patients who are judged inappropriate for the study responsible doctor
研究者
相似试验
招募中
2 期
RCT of TJ-3020 in patients with unresectable advanced or recurrent pancreatic cancer receiving nab-Paclitaxel plus GemcitabinePancreatic cancerPncreatic cancerJPRN-jRCTs041190040Kodera Yasuhiro56
未知
2 期
Phase 2 Dose-Finding Study of JTT-305 in Patients with Primary Osteoporosis.JPRN-jRCT2080220803JAPAN TABACCO INC.320
未知
2 期
Phase II clinical study of TY-0201 in patients with chronic heart failureChronic heart failureJPRN-jRCT2080222593TOA EIYO LTD.40
进行中（未招募）
3 期
JCOG1016: Phase III randomized study for anaplastic glioma of radiotherapy with temozolomide vs. ACNU followed by temozolomideanaplastic gliomaJPRN-jRCTs031180215MURAGAKI Yoshihiro280
已完成
不适用
Phase I clinical trial of JPH203 in patients with solid cancers.Solid cancersJPRN-UMIN000016546J-Pharma Co., Ltd.21